ZA939477B - Insulin analogs - Google Patents

Insulin analogs

Info

Publication number
ZA939477B
ZA939477B ZA939477A ZA939477A ZA939477B ZA 939477 B ZA939477 B ZA 939477B ZA 939477 A ZA939477 A ZA 939477A ZA 939477 A ZA939477 A ZA 939477A ZA 939477 B ZA939477 B ZA 939477B
Authority
ZA
South Africa
Prior art keywords
insulin analogs
insulin
analogs
Prior art date
Application number
ZA939477A
Other languages
English (en)
Inventor
Ronald Eugene Chance Li Fan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA939477B publication Critical patent/ZA939477B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA939477A 1992-12-18 1993-12-17 Insulin analogs ZA939477B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99565992A 1992-12-18 1992-12-18

Publications (1)

Publication Number Publication Date
ZA939477B true ZA939477B (en) 1995-06-19

Family

ID=25542078

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA939477A ZA939477B (en) 1992-12-18 1993-12-17 Insulin analogs

Country Status (14)

Country Link
EP (1) EP0605983A3 (pt)
JP (1) JPH08504820A (pt)
CN (1) CN1094059A (pt)
AU (1) AU680462B2 (pt)
BR (1) BR9307687A (pt)
CA (1) CA2151134A1 (pt)
CZ (1) CZ158895A3 (pt)
FI (1) FI953001A0 (pt)
HU (1) HUT71583A (pt)
MX (1) MX9307991A (pt)
NO (1) NO952336L (pt)
PL (1) PL310007A1 (pt)
WO (1) WO1994014461A1 (pt)
ZA (1) ZA939477B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559094A (en) * 1994-08-02 1996-09-24 Eli Lilly And Company AspB1 insulin analogs
CN1125081C (zh) * 1999-09-08 2003-10-22 中国科学院上海生物化学研究所 重组天然和新型人胰岛素及其制备方法
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
PT3228320T (pt) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combinação de uma insulina e de um agonista do glp-1
RU2537239C2 (ru) 2009-11-13 2014-12-27 Санофи-Авентис Дойчланд Гмбх Фармацевтическая композиция, включающая агонист glp-1, инсулин и метионин
PT2498801T (pt) 2009-11-13 2018-05-02 Sanofi Aventis Deutschland Composição farmacêutica compreendendo despro36exendin-4(1-39)-lys6-nh2 e metionina
RU2546520C2 (ru) 2010-08-30 2015-04-10 Санофи-Авентис Дойчланд Гмбх Применение ave0010 для производства лекарственного средства для лечения сахарного диабета 2 типа
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
ES2550357T3 (es) 2011-08-29 2015-11-06 Sanofi-Aventis Deutschland Gmbh Combinación farmacéutica para su uso en el control glucémico en pacientes de diabetes de tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
CN108383902A (zh) * 2012-09-26 2018-08-10 印第安纳大学研究及科技有限公司 胰岛素类似物二聚体
HUE062573T2 (hu) 2014-12-12 2023-11-28 Sanofi Aventis Deutschland Glargin inzulin/lixiszenatid rögzített arányú készítmény
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
CA2071382A1 (en) * 1991-06-21 1992-12-22 David N. Brems Insulin analogs

Also Published As

Publication number Publication date
JPH08504820A (ja) 1996-05-28
CN1094059A (zh) 1994-10-26
FI953001A (fi) 1995-06-16
NO952336D0 (no) 1995-06-13
CZ158895A3 (en) 1995-12-13
HUT71583A (en) 1995-12-28
CA2151134A1 (en) 1994-07-07
AU5827994A (en) 1994-07-19
BR9307687A (pt) 2002-02-19
NO952336L (no) 1995-06-13
WO1994014461A1 (en) 1994-07-07
PL310007A1 (en) 1995-11-13
HU9501762D0 (en) 1995-08-28
AU680462B2 (en) 1997-07-31
EP0605983A3 (en) 1995-06-07
FI953001A0 (fi) 1995-06-16
EP0605983A2 (en) 1994-07-13
MX9307991A (es) 1994-08-31

Similar Documents

Publication Publication Date Title
ZA939317B (en) Medicament
ZA939477B (en) Insulin analogs
GB2256146B (en) Syringe
HK1000347A1 (en) Syringe
IL102240A0 (en) Insulin analogs
GB9016375D0 (en) Syringe
GB9219302D0 (en) Improvements relating to syringe
GB9205505D0 (en) Cyclic compounds
ZA90838B (en) Insulin analogs
HU9402245D0 (en) Syringe
GB9224973D0 (en) Syringe
ZA935302B (en) Syringe
PL304717A1 (en) Syringe
GB9215876D0 (en) Syringe
GB9219443D0 (en) Syringes
GB9101479D0 (en) Improved syringe
IL120356A0 (en) Hydantocidin analogs
CA66344S (en) Syringe
CA65932S (en) Syringe
CA66409S (en) Syringe
GB9108155D0 (en) Syringe
PL291516A1 (en) Syringe
GB9117800D0 (en) Syringe
GB9120052D0 (en) Syringe
IL101141A0 (en) Syringe